503 related articles for article (PubMed ID: 28133811)
1. Complex immune correlates of protection in HIV-1 vaccine efficacy trials.
Tomaras GD; Plotkin SA
Immunol Rev; 2017 Jan; 275(1):245-261. PubMed ID: 28133811
[TBL] [Abstract][Full Text] [Related]
2. Prospects for a globally effective HIV-1 vaccine.
Excler JL; Robb ML; Kim JH
Vaccine; 2015 Nov; 33 Suppl 4():D4-12. PubMed ID: 26100921
[TBL] [Abstract][Full Text] [Related]
3. New concepts in HIV-1 vaccine development.
Stephenson KE; D'Couto HT; Barouch DH
Curr Opin Immunol; 2016 Aug; 41():39-46. PubMed ID: 27268856
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the development of an HIV-1 vaccine.
Barouch DH
Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 vaccines and adaptive trial designs.
Corey L; Nabel GJ; Dieffenbach C; Gilbert P; Haynes BF; Johnston M; Kublin J; Lane HC; Pantaleo G; Picker LJ; Fauci AS
Sci Transl Med; 2011 Apr; 3(79):79ps13. PubMed ID: 21508308
[TBL] [Abstract][Full Text] [Related]
6. Advances in HIV-1 Vaccine Development.
Gao Y; McKay PF; Mann JFS
Viruses; 2018 Apr; 10(4):. PubMed ID: 29614779
[TBL] [Abstract][Full Text] [Related]
7. Systems serology for evaluation of HIV vaccine trials.
Ackerman ME; Barouch DH; Alter G
Immunol Rev; 2017 Jan; 275(1):262-270. PubMed ID: 28133810
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
Girard MP; Osmanov S; Assossou OM; Kieny MP
Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
[TBL] [Abstract][Full Text] [Related]
9. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.
Fouts TR; Bagley K; Prado IJ; Bobb KL; Schwartz JA; Xu R; Zagursky RJ; Egan MA; Eldridge JH; LaBranche CC; Montefiori DC; Le Buanec H; Zagury D; Pal R; Pavlakis GN; Felber BK; Franchini G; Gordon S; Vaccari M; Lewis GK; DeVico AL; Gallo RC
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):E992-9. PubMed ID: 25681373
[TBL] [Abstract][Full Text] [Related]
10. Moving the HIV vaccine field forward: concepts of protective immunity.
Kent SJ; Davenport MP
Lancet HIV; 2019 Jun; 6(6):e406-e410. PubMed ID: 31080107
[TBL] [Abstract][Full Text] [Related]
11. HIV vaccine efficacy and immune correlates of risk.
O'Connell RJ; Excler JL
Curr HIV Res; 2013 Sep; 11(6):450-63. PubMed ID: 24033301
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus antibodies and the vaccine problem.
Chiodi F; Weiss RA
J Intern Med; 2014 May; 275(5):444-55. PubMed ID: 24581142
[TBL] [Abstract][Full Text] [Related]
13. Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.
Rolland M; Gilbert P
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):400-4. PubMed ID: 21902593
[TBL] [Abstract][Full Text] [Related]
14. HIV vaccine development at the turn of the 21st century.
Girard MP; Plotkin SA
Curr Opin HIV AIDS; 2012 Jan; 7(1):4-9. PubMed ID: 22156840
[TBL] [Abstract][Full Text] [Related]
15. Prospects for a Globally Effective HIV-1 Vaccine.
Excler JL; Robb ML; Kim JH
Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S307-18. PubMed ID: 26590431
[TBL] [Abstract][Full Text] [Related]
16. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.
Chung AW; Kumar MP; Arnold KB; Yu WH; Schoen MK; Dunphy LJ; Suscovich TJ; Frahm N; Linde C; Mahan AE; Hoffner M; Streeck H; Ackerman ME; McElrath MJ; Schuitemaker H; Pau MG; Baden LR; Kim JH; Michael NL; Barouch DH; Lauffenburger DA; Alter G
Cell; 2015 Nov; 163(4):988-98. PubMed ID: 26544943
[TBL] [Abstract][Full Text] [Related]
17. The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.
Koup RA; Graham BS; Douek DC
Nat Rev Immunol; 2011 Jan; 11(1):65-70. PubMed ID: 21164527
[TBL] [Abstract][Full Text] [Related]
18. Prospects for vaccine protection against HIV-1 infection and AIDS.
Letvin NL; Barouch DH; Montefiori DC
Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
[TBL] [Abstract][Full Text] [Related]
19. The Antibodiome-Mapping the Humoral Immune Response to HIV.
Butler AL; Fischinger S; Alter G
Curr HIV/AIDS Rep; 2019 Apr; 16(2):169-179. PubMed ID: 30903381
[TBL] [Abstract][Full Text] [Related]
20. Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.
Dimitrov D; Kublin JG; Ramsey S; Corey L
EBioMedicine; 2015 Dec; 2(12):2062-9. PubMed ID: 26844286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
